Finance

Lists
Why is 9969 up 2,67%?
Dive Deeper
9969:HKG
InnoCare Pharma Ltd
HK$12,32
+2,67%
(+0,32) 1D
16 Okt., 16:08:14 GMT+8  ·   HKD
All symbols
SymbolPriceChange% Change
Generating top insights for 9969...
Open
HK$12,20
High
HK$12,64
Low
HK$12,01
Mkt. cap
26,72 mjd
Avg. vol.
8,46 m
Volume
7,54 m
P/E ratio
28,00
52-wk high
HK$16,20
52-wk low
HK$9,65
EPS
HK$0,44
No. of employees
1 k
Open
HK$12,20
High
HK$12,64
Low
HK$12,01
Mkt. cap
26,72 mjd
Avg. vol.
8,46 m
Volume
7,54 m
P/E ratio
28,00
52-wk high
HK$16,20
52-wk low
HK$9,65
EPS
HK$0,44
No. of employees
1 k
News stories
From web sources and news partners
About InnoCare Pharma Ltd
CEOJasmine Cui
Employees1,39 k
Founded03 Nov. 2015
Headquarters-
Sector-
Websiteinnocarepharma.com
Next call oor 8 dae
Ma. 26 Okt., 10:00
Fiscal period
Q3 2026
- / -
Revenue / Est. (CNY)
- / 691,21 m
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
383,89 m
1,26 mjd
528,63 m
608,43 m
Cost of goods sold
48,46 m
66,11 m
62,72 m
56,27 m
Cost of revenue
48,46 m
66,11 m
62,72 m
56,27 m
Research and development expenses
226,35 m
275,57 m
229,16 m
267,92 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
187,93 m
243,50 m
162,45 m
205,62 m
Operating expense
388,22 m
560,08 m
392,10 m
476,27 m
Total operating expenses
436,68 m
626,19 m
454,82 m
532,54 m
Operating income
-52,79 m
633,39 m
73,81 m
75,89 m
Other non operating income
26,02 m
-26,67 m
11,13 m
-13,40 m
EBT including unusual items
-33,60 m
719,92 m
104,85 m
142,30 m
EBT excluding unusual items
-8,17 m
673,62 m
101,24 m
102,50 m
Income tax expense
2,72 m
3,79 m
2,40 m
5,07 m
Effective tax rate
-8,09%
0,53%
2,29%
3,57%
Other operating expenses
-25,90 m
40,29 m
-320,57 k
3,37 m
Net income
-34,32 m
706,88 m
105,82 m
140,54 m
Net profit margin
-8,94%
56,12%
20,02%
23,10%
Earnings per share
-
-
-
-
Interest and investment income
44,67 m
47,46 m
30,69 m
37,25 m
Interest expense
-14,49 m
-12,42 m
-14,38 m
-15,13 m
Net interest expenses
30,17 m
35,04 m
16,30 m
22,12 m
Depreciation and amortization charges
-
-
-
-
EBITDA
-36,03 m
652,95 m
93,37 m
94,23 m
Gain or loss from assets sale
3,40 k
-3,40 k
-
-197,23 k
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme